Lamivudine in the Treatment of Acute Hepatitis B
- 12 October 2000
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 343 (15) , 1123-1124
- https://doi.org/10.1056/nejm200010123431513
Abstract
Lamivudine, a nucleoside analogue, has shown promising results in the treatment of hepatitis B virus (HBV) infection through its inhibitory action on reverse-transcriptase activity.1,2 Lamivudine has been used to treat acute hepatitis B after liver transplantation and heart transplantation, and there are now preliminary results from a multicenter trial of its use after liver transplantation.3,4 We report the use of lamivudine in a 74-year-old woman with acute hepatitis B.Keywords
This publication has 5 references indexed in Scilit:
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Lamivudine treatment for acute hepatitis B after liver transplantationJournal of Hepatology, 1998
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Hepatitis and Cholestasis in A Middle–Aged WomanHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995